Latest stories on CLNN
Clene (CLNN) Q3 Earnings Beat EPS Estimates but Revenue Misses Expectations
GuruFocus48 · neutralearnings
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene Moves CNM-Au8 Into the FDA Review Queue With ALS Accelerated-Approval NDA
October 20, 2026
MarketChameleon64 · neutralproduct/pr
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
GlobeNewswire64 · neutralproduct/pr
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Business Insider63 · neutralproduct/pr
Clene to Present at Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Clene to Present at Upcoming Investor Conferences
GlobeNewswire56 · neutralgeneral
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
Business Insider24 · bearishgeneral
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
GlobeNewswire28 · bearishgeneral
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene prices 1.22M shares at $3.28 in registered direct offering
The Fly28 · bearishgeneral
Clene Announces $4 Million Registered Direct Offering
GlobeNewswire24 · bearishgeneral
Clene Announces $4 Million Registered Direct Offering
StockTitan24 · bearishgeneral
Clene to Present at Upcoming September Investor Conferences
GlobeNewswire56 · neutralgeneral
Clene to Present at Upcoming September Investor Conferences
Business Insider56 · neutralgeneral
Clene to Present at the Emerging Growth Conference
GlobeNewswire56 · neutralgeneral
Clene to Present at the Emerging Growth Conference
Business Insider56 · neutralgeneral
Clene GAAP EPS of -$1.08 misses by $0.71
Seeking Alpha28 · bearishearnings
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene Reports Second Quarter 2026 Financial Results and Recent Operating Highlights
GlobeNewswire59 · neutralearnings
Clene Inc. (CLNN) files 8-K
SEC 8-K50 · neutralgeneral
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
StockTitan73 · bullishproduct/pr
Clene to Present at The Canaccord 46th Annual Growth Conference
StockTitan56 · neutralgeneral